AU8714991A - 4-acetoxy-piperidine derivatives, process for their preparation and use as a muscarinic m3-receptor antagonist - Google Patents

4-acetoxy-piperidine derivatives, process for their preparation and use as a muscarinic m3-receptor antagonist

Info

Publication number
AU8714991A
AU8714991A AU87149/91A AU8714991A AU8714991A AU 8714991 A AU8714991 A AU 8714991A AU 87149/91 A AU87149/91 A AU 87149/91A AU 8714991 A AU8714991 A AU 8714991A AU 8714991 A AU8714991 A AU 8714991A
Authority
AU
Australia
Prior art keywords
compound
formula
group
quaternary ammonium
ammonium salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU87149/91A
Other languages
English (en)
Inventor
Richard Bawden Barlow
Mark Anthony Veale
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
British Technology Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Technology Group Ltd filed Critical British Technology Group Ltd
Publication of AU8714991A publication Critical patent/AU8714991A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU87149/91A 1990-10-23 1991-10-17 4-acetoxy-piperidine derivatives, process for their preparation and use as a muscarinic m3-receptor antagonist Abandoned AU8714991A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909023023A GB9023023D0 (en) 1990-10-23 1990-10-23 Pharmaceutical compositions
GB9023023 1990-10-23

Publications (1)

Publication Number Publication Date
AU8714991A true AU8714991A (en) 1992-05-20

Family

ID=10684199

Family Applications (1)

Application Number Title Priority Date Filing Date
AU87149/91A Abandoned AU8714991A (en) 1990-10-23 1991-10-17 4-acetoxy-piperidine derivatives, process for their preparation and use as a muscarinic m3-receptor antagonist

Country Status (9)

Country Link
EP (1) EP0506903A1 (de)
JP (1) JPH05504578A (de)
AU (1) AU8714991A (de)
CA (1) CA2072598A1 (de)
FI (1) FI922903A (de)
GB (2) GB9023023D0 (de)
PT (1) PT99299A (de)
WO (1) WO1992006958A1 (de)
ZA (1) ZA918381B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7545894A (en) * 1993-09-02 1995-03-22 Yamanouchi Pharmaceutical Co., Ltd. Carbamate derivative and medicine containing the same
NO2005012I1 (no) 1994-12-28 2005-06-06 Debio Rech Pharma Sa Triptorelin og farmasoytisk akseptable salter derav
CA2179574A1 (en) * 1995-06-26 1996-12-27 Tomomi Okada Substituted piperidine derivative and medicine comprising the same
PE92198A1 (es) * 1996-08-01 1999-01-09 Banyu Pharma Co Ltd Derivados de 1,4-piperidina disustituida que contienen fluor
PE20050231A1 (es) * 2003-06-24 2005-05-20 Novartis Ag Derivados de piperidinium y pirrolidinium como antagonistas del receptor muscarinico m3
GB0428418D0 (en) * 2004-12-24 2005-02-02 Novartis Ag Organic compounds
EP3233799B1 (de) * 2014-12-19 2021-05-19 The Broad Institute, Inc. Dopamin-d2-rezeptor-liganden
EP3233077A4 (de) 2014-12-19 2018-08-08 The Broad Institute Inc. Dopamin-d2-rezeptor-liganden

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792043A (fr) * 1971-11-30 1973-05-29 Ciba Geigy Derives de la piperidine utilisables pour stabiliser des matieres organiques
IT1231238B (it) * 1987-09-21 1991-11-26 Angeli Inst Spa Derivati ammidinici

Also Published As

Publication number Publication date
GB9122083D0 (en) 1991-11-27
EP0506903A1 (de) 1992-10-07
WO1992006958A1 (en) 1992-04-30
CA2072598A1 (en) 1992-04-24
GB2249093A (en) 1992-04-29
ZA918381B (en) 1993-04-21
GB9023023D0 (en) 1990-12-05
FI922903A0 (fi) 1992-06-22
FI922903A (fi) 1992-06-22
JPH05504578A (ja) 1993-07-15
PT99299A (pt) 1992-08-31

Similar Documents

Publication Publication Date Title
DE60129210T2 (de) Zyklische amid-derivate
PL192397B1 (pl) Pochodna 1-(1,2-dipodstawionej piperydynylo)-4-piperydyny, jej zastosowanie, sposób wytwarzania i kompozycja farmaceutyczna
DE3889133T2 (de) N-Heterocyclische N-(4-Piperidyl)-amide.
WO1995006635A1 (fr) Derive de carbamate et medicament le contenant
AU673754B2 (en) Tetrazole derivatives having antihistaminic and antiallergic activity
US10106522B2 (en) Benzimidazole derivatives as antihistamine agents
DE69012650T2 (de) Piperidinderivat, Verfahren zur Herstellung davon und dieses enthaltende pharmazeutische Zusammensetzung.
RU2188197C2 (ru) 1,4-дизамещенные пиперазины, способ их получения, фармацевтическая композиция и способ лечения нейрогенного воспаления
AU8714991A (en) 4-acetoxy-piperidine derivatives, process for their preparation and use as a muscarinic m3-receptor antagonist
WO2001044193A1 (en) 1,3,4-substituted piperidine analogs and uses thereof in treating addictions
DE68917185T2 (de) 4-Aryl-4-piperidine (oder -pyrrolidin- oder -hexahydroazepin-) carbinole und heterocyclische Analoga davon.
MXPA99003106A (es) Compuestos azaheterociclicos n-sustituidos.
AU688186B2 (en) (Thiophen-2-YL)-piperidin or tetrahydropyridin carboxamides
Martin-Smith et al. Relationships between the chemical structure and pharmacological activity in a series of synthetic quinuclidine derivatives
US5753678A (en) Heterocyclic compounds
WO1993007122A1 (en) 4-diphenylacetoxy-n-substituted piperidines with antimuscarinic activity
EP0364091B1 (de) Verbrückte bicyclische 4-(4-(3-Benzisothiazolyl)-1-piperazinyl)-butylimide mit antipsychotischer Wirkung
US4716166A (en) Histamine H1 antagonists
EP0451772A1 (de) Piperidinverbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
JPH0741481A (ja) 両性型三環系化合物
US4205074A (en) Anti-spasmodic substituted quinolizidine and indolizidine compounds
US20040038966A1 (en) Cyclic amine derivatives and use thereof
EP0785195A1 (de) Piperidin- oder Tetrahydropyridin-Derivate mit Serotonin 5-HTIA-Rezeptor-Affinität
EP0707579B1 (de) Piperidinyl-substituierte methanoanthracene als d1/d2-antagonisten und 5ht2-serotonin-antagonisten
WO1996031471A1 (en) Novel method